Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 3.010
+0.060 (2.03%)
Apr 24, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 593.34 million as of April 24, 2025. Its market cap has increased by 17.43% in one year.
Market Cap
593.34M
Enterprise Value
887.49M
Revenue
728.27M
Ranking
n/a
PE Ratio
19.60
Stock Price
3.01
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 593.34M, a decrease of -14.04%. That is a compound annual growth rate of -3.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 593.34M | -13.32% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 117.13B |
| Pro Medicus | 22.02B |
| Cochlear | 17.31B |
| Sonic Healthcare | 12.25B |
| Telix Pharmaceuticals | 9.65B |
| Ramsay Health Care | 7.63B |
| Ansell | 4.26B |
| Mesoblast | 2.29B |